BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24867532)

  • 1. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.
    Frank SJ; Cox JD; Gillin M; Mohan R; Garden AS; Rosenthal DI; Gunn GB; Weber RS; Kies MS; Lewin JS; Munsell MF; Palmer MB; Sahoo N; Zhang X; Liu W; Zhu XR
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):846-53. PubMed ID: 24867532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas.
    Hague C; Aznar M; Dong L; Fotouhi-Ghiam A; Lee LW; Li T; Lin A; Lowe M; Lukens JN; McPartlin A; O'Reilly S; Slevin N; Swisher-Mcclure S; Thomson D; Van Herk M; West C; Zou W; Teo BK
    Br J Radiol; 2020 Mar; 93(1107):20190638. PubMed ID: 31845816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
    Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.
    Gunn GB; Blanchard P; Garden AS; Zhu XR; Fuller CD; Mohamed AS; Morrison WH; Phan J; Beadle BM; Skinner HD; Sturgis EM; Kies MS; Hutcheson KA; Rosenthal DI; Mohan R; Gillin MT; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):360-367. PubMed ID: 27084653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
    Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
    Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
    Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
    Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
    de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
    Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
    Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
    Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
    Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
    Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
    JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.
    Gu W; O'Connor D; Nguyen D; Yu VY; Ruan D; Dong L; Sheng K
    Med Phys; 2018 Apr; 45(4):1338-1350. PubMed ID: 29394454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
    Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
    Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust optimization for intensity-modulated proton therapy with soft spot sensitivity regularization.
    Gu W; Ruan D; O'Connor D; Zou W; Dong L; Tsai MY; Jia X; Sheng K
    Med Phys; 2019 Mar; 46(3):1408-1425. PubMed ID: 30570164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer.
    Quan EM; Liu W; Wu R; Li Y; Frank SJ; Zhang X; Zhu XR; Mohan R
    Med Phys; 2013 Aug; 40(8):081709. PubMed ID: 23927306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.
    Lalonde A; Bobić M; Sharp GC; Chamseddine I; Winey B; Paganetti H
    Phys Med Biol; 2023 May; 68(11):. PubMed ID: 37164020
    [No Abstract]   [Full Text] [Related]  

  • 18. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
    Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison.
    Nguyen ML; Cantrell JN; Ahmad S; Henson C
    Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
    Yeung D; McKenzie C; Indelicato DJ
    Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.